How to read a thyroid panel — TSH, free T4, free T3, reverse T3, and antibodies

The labs showed something. The question is whether they showed everything.

A thyroid panel is not one number. It's a system of interconnected signals, and reading each marker in isolation while ignoring what the others are doing is how you end up told you're normal while feeling genuinely unwell. Let's walk through what each marker actually measures and why the gap between "within reference range" and "functioning optimally" matters for how you interpret your results.

TSH — thyroid-stimulating hormone — is the marker most labs run first, and in many standard panels, it's the only marker run unless the TSH is abnormal. That practice reflects a particular view of the thyroid axis, which goes like this: the pituitary gland monitors circulating thyroid hormone levels and adjusts its output of TSH accordingly. If thyroid hormone is low, TSH rises — the pituitary is pushing harder to stimulate the thyroid to produce more. If thyroid hormone is high, TSH falls — the pituitary backs off. So a normal TSH, in this model, means the pituitary is satisfied with what the thyroid is producing, which means thyroid output is adequate.

This logic is correct as far as it goes. But it assumes a few things that don't always hold. It assumes the pituitary is healthy and its signaling is accurate. It assumes that peripheral conversion of thyroid hormone — the process by which the body activates thyroid hormone after it leaves the gland — is working normally. It assumes that cells are responding appropriately to thyroid hormone at the receptor level. And it assumes that the reference range for TSH, derived from a population that may include people with subclinical thyroid dysfunction, accurately captures what a healthy thyroid axis looks like. Each of those assumptions is sometimes wrong.

The reference range for TSH at most labs runs from approximately 0.4 to 4.0 or 4.5 mIU/L, depending on the lab. There is genuine controversy about the upper end of that range. Some endocrinology societies have debated whether the upper reference limit should be lower — around 2.5 mIU/L — particularly for women who are pregnant or trying to conceive, and some functional medicine practitioners argue that a TSH above 2.0 in a symptomatic patient is worth taking seriously even when it falls within the standard range. The mainstream position remains that a TSH within reference range does not warrant treatment. The functional medicine position is that symptoms, clinical picture, and the rest of the panel matter as much as where the TSH lands within the range.

Free T4 is the next marker. T4 is the primary hormone the thyroid gland synthesizes and releases into circulation. It's called the storage form — most of it circulates bound to carrier proteins, and a small fraction circulates freely. Free T4 is the unbound fraction, and it's the clinically relevant measurement. T4 is relatively inactive at the tissue level. Its role in most cells is to serve as a precursor — the raw material for producing T3, which is the biologically active thyroid hormone.

Free T3 is where the biology actually happens. T3 — triiodothyronine — is roughly three to four times more biologically potent than T4 at the receptor level. It's produced partly by the thyroid gland directly, but the majority of circulating T3 is produced outside the thyroid, by peripheral conversion of T4 to T3 through an enzyme class called deiodinases. This conversion happens in many tissues — liver, kidney, muscle, brain — and it's the step that turns thyroid output into metabolic activity. If free T4 is normal but free T3 is low, the problem isn't the thyroid's production — it's the conversion. That pattern can appear with chronic inflammation, caloric restriction, high cortisol, selenium deficiency, certain medications, and various chronic illness states. And it can produce the full clinical picture of hypothyroidism — the fatigue, the cold intolerance, the cognitive sluggishness, the weight resistance — while TSH stays comfortably within normal limits.

This is a real phenomenon. It has multiple names: low T3 syndrome, euthyroid sick syndrome when it occurs in the context of acute illness, non-thyroidal illness syndrome in other contexts. Most standard medical practice does not treat isolated low T3 in the absence of elevated TSH. Functional medicine practitioners often flag it as clinically significant, particularly when symptoms correlate. Whether and how to address impaired T4-to-T3 conversion is a clinical judgment call that belongs with your prescribing provider — but knowing it's a pattern worth asking about is useful.

Reverse T3 is an isomer of T3. When T4 is converted, it doesn't always become active T3. Under certain conditions, it becomes reverse T3 instead — a molecule with the same molecular formula as T3 but a different structure, which means it binds to T3 receptors without activating them. Reverse T3 is, in effect, a competitive blocker. Elevated reverse T3 means more of your T4 is being converted down a pathway that creates receptor occupation without function rather than genuine thyroid hormone activity. The conditions that drive elevated reverse T3 read like a list of common chronic stressors: high cortisol, caloric restriction, fasting, critical illness, heavy exercise without adequate recovery, iron deficiency, and certain medications. Some practitioners calculate a free T3-to-reverse T3 ratio as a marker of thyroid hormone "efficiency" — how much active T3 is available relative to the blocker. This ratio is not universally validated in the mainstream literature, but it represents a coherent biological question worth discussing with a provider who's familiar with the interpretation.

Thyroid antibodies — specifically thyroid peroxidase antibodies (TPO-Ab) and thyroglobulin antibodies (TGAb) — are markers of autoimmune thyroid disease, specifically Hashimoto's thyroiditis. Hashimoto's is an autoimmune condition in which the immune system produces antibodies that attack thyroid tissue. Over years, this immune-mediated damage can progressively impair thyroid function, eventually resulting in frank hypothyroidism. But the crucial thing about antibodies is that they can be significantly elevated long before TSH becomes abnormal. The gland can compensate for immune damage for years, maintaining normal hormone output even as the tissue is being slowly degraded, while antibodies in the thousands are present the entire time. Someone with strongly positive TPO antibodies and a normal TSH is not the same clinically as someone with negative antibodies and a normal TSH. The first person has autoimmune thyroid disease that may or may not have yet affected thyroid function. The trajectory is different. The monitoring frequency should be different. The interventions being considered — including immune modulation, dietary changes like gluten elimination that some research suggests may affect antibody levels in Hashimoto's, and selenium supplementation that some research has associated with reduced TPO antibody titers — are worth discussing with a provider even while the TSH is still normal.

The subclinical hypothyroidism category is where a lot of this lands. Subclinical hypothyroidism is formally defined as elevated TSH with normal free T4 — the pituitary is working hard, the thyroid is still compensating, but the signs of strain are visible in the TSH signal. The question of whether to treat subclinical hypothyroidism is one of the more genuinely contested areas in thyroid medicine. Most endocrinology guidelines recommend treatment when TSH is above 10 mIU/L, and suggest clinical judgment (considering symptoms, age, cardiovascular risk, antibody status) for TSH between 4.5 and 10. Functional practitioners often lean toward treatment at lower TSH thresholds, especially in symptomatic patients. The evidence base for treating mild subclinical hypothyroidism is genuinely mixed — some trials show symptom benefit, others show modest effect — and the appropriate path depends on your individual clinical picture, not on which camp your provider belongs to.

The medication conversation is worth raising explicitly because it's where a lot of the practical decisions live. Standard treatment for hypothyroidism in most clinical settings is levothyroxine — synthetic T4. If the conversion from T4 to T3 is efficient, this is sufficient. But for people with impaired conversion — where the free T3 remains low despite normalized TSH on T4 therapy — T4-only treatment may not fully resolve symptoms. The options include adding liothyronine (synthetic T3) to levothyroxine, or switching to natural desiccated thyroid (NDT) preparations, which contain both T4 and T3. The T3 question remains contested in mainstream endocrinology — the position is that T4 monotherapy is sufficient for most patients — but a meaningful subset of patients report persistent symptoms on T4 alone that improve with T3 addition. Whether this reflects true impaired conversion, receptor sensitivity differences, or other factors is still being researched. It's a conversation worth having with your prescribing provider if your free T3 is consistently low despite normal TSH and T4 on levothyroxine.

Thyroid status integrates with almost everything else. Thyroid hormone drives basal metabolic rate — it's one of the primary determinants of how many calories your body burns at rest. It affects heart rate, body temperature, bowel motility, hair growth, skin quality, cholesterol metabolism, and mood. The cognitive effects of even mild hypothyroidism are well-documented: brain fog, slower processing, difficulty with word retrieval, low motivation. The metabolic effects — slowed metabolism, weight gain, elevated LDL cholesterol, fatigue with exercise — look like a dozen other conditions and are often attributed to aging, stress, or lifestyle before thyroid function is fully interrogated.

What this means practically is that a thyroid panel is worth reading in full, not just at the TSH. If you have the symptoms and a normal TSH, the rest of the panel matters. If you have a normal TSH and elevated antibodies, the antibodies matter. If you have a normal TSH and a low free T3, the conversion question matters. And in all of these cases, interpreting what the numbers mean in your specific clinical context — your symptoms, your history, what else is happening in your health picture — is the work of a provider who can sit with the full picture, not a reference range on a lab printout.

The number being normal is information. It is not a conclusion.